Protection from T cell-mediated murine liver failure by phosphodiesterase inhibitors

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 1, 1997, Pages 53-60

  Gantner, Florian ^a   Küsters, Sabine ^a   Wendel, Albrecht ^a   Hatzelmann, Armin ^b   Schudt, Christian ^b   Tiegs, Gisa ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b ALTANA PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; MOTAPIZONE; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; DRUG SELECTIVITY; IMMUNOPATHOGENESIS; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER FAILURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; INTERLEUKIN-10; INTERLEUKIN-4; LIVER FAILURE; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; PHOSPHODIESTERASE INHIBITORS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030941551     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. ARAI, T., HIROMATSU, K., KOBAYASHI, N., MANABU, T., ISHDA, H., NIMURA, Y. AND YOSHIKAI, Y.: IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury. J. Immunol. 155: 5743-5749, 1995.
2. BARSIG, J., KÜSTERS, S., VOGT, K., VOLK, H.-D., TIEGS, G. AND WENDEL, A.: Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-α. Eur. J. Immunol. 25: 2888-2893, 1995.
3. BEAN, A. G. D., FREIBERG, R. A., ANDRADE, S., MENON, S. AND ZLOTNIK, A.: Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect. Immun. 61: 4937-4939, 1993.
4. BOGDAN, G., VODOVOTZ, Y. AND NATHAN, C.: Macrophage deactivation by interleukin 10. J. Exp. Med. 174: 1549-1555, 1991.
5. DENDORFER, U., OETTGEN, P. AND LIEBERMANN, T. A.: Multiple regulatory elements in the interleukin-6 gene mediate induction of prostaglandins, cyclic AMP, and lipopolysaccharide. Mol. Cell Biol. 14: 4443-4454, 1994.
6. ESSAYAN, D. M., HUANG, S-K., UNDEM, B. J., KAGEY-SUBOTKA, A. AND LICHTENSTEIN, L. M.: Modulation of antigen- and mitogen-induced proliferative responses of peripheral blood mononuclear cells by nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors. J. Immunol. 153: 3408-3416, 1994.
7. FIORENTINO, D. F., ZLOTNIK, A., MOSMANN, T. R., ZOWARD, M. AND O'GARRA, A.: IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815-3822, 1991.
8. FISCHER, W., SCHUDT, C. AND WENDEL, A.: Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice. Biochem. Pharmacol. 45: 2399-2404, 1993.
9. FLORQUIN, S., AMRAOUI, Z., ABRAMOWICZ, D. AND GOLDMAN, M.: Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J. Immunol. 153: 2618-2623, 1994.
10. GALANOS, C., FREUDENBERG, M. A. AND REUTTER, W. R.: Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. U.S.A. 76: 5939-5943, 1979.
11. GANTNER, F., LEIST, M., JILG, S., GERMANN, P. G., FREUDENBERG, M. A. AND TIEGS, G: Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology 109: 166-176, 1995a.
12. GANTNER, F., LEIST, M., LOHSE, A. W., GERMANN, P. G. AND TIEGS, G.: Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21: 190-198, 1995b.
13. GANTNER, F., SCHUDT, C., WENDEL, A. AND HATZELMANN, A.: Synergistic inhibition of human T cell proliferation by PDE III and PDE IV inhibitors. Inflamm. Res. 44: S263, 1995c.
14. GENAIN, C. P., ROBERTS, T., DAVIS, R. L., NGUYEN, M-H., UCCELLI, A., FAULDS, D., Li, Y., HEDGPETH, J. AND HAUSER, S. L.: Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiestase inhibitor. Proc. Natl. Acad. Sci. U.S.A. 92: 3601-3605, 1995.
15. GOLDFELD, A. E., TSAI, E., KINCAID, R., BELSHAW, P. J., SCHRIEBER, S. L., STROMINGER, J. L. AND RAO, A.: Calcineurin mediates human tumor necrosis factor alpha gene induction in stimulated T and B cells. J. Exp. Med. 180: 763-768, 1994.
16. HARAGUCHI, S., GOOD, R. A. AND DAY, N. K.: Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol. Today 16: 595-603, 1995.
17. HORDER, M. AND REJ, R.: Alanine aminotransferase. In Methods of Enzymatic Analysis, ed. by H. U. Bergmeyer, pp. 444-456, Verlag Chemie, Weinheim, 1984.
18. JILG, S., BARSIG, J., LEIST, M., KÜSTERS, S., VOLK, H. D. AND WENDEL, A.: Enhanced induction of interleukin-10 and shedding of tumor necrosis factor receptors as possible protective principles of methylxanthines in murine models of endotoxic shock. J. Pharmacol. Exp. Ther. 278: 421-431, 1996.
19. JONES, A. L. AND SELBY, P.: Tumor necrosis factor: clinical relevance. Cancer Survey 8: 817-836, 1989.
20. KAMBAYASHI, T., JACOB, C. O., ZHOU, D., MAZUREK, N., FONG, M. AND STRASSMANN, G.: Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages. J. Immunol. 155: 4909-4916, 1995.
21. KIM, J. M., BRANNAN, C. I., COPELAND, N. G., JENKINS, N. A., KHAN, T. A. AND MOORE, K. W.: Structure of the mouse IL-10 gene and chromosomal localization of the mouse and the human IL-10 genes. J. Immunol. 148: 3618-3623, 1992.
22. KÜSTERS, S., GANTNER, F., KÜNSTLE, G. AND TIEGS, G.: Interferon-γ plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111: 462-471, 1996.
23. LACOUR, M., ARRIGHUI, J. F., MULLER, K. M., CARLBERG, C., SAURAT, J. H. AND HAUSER, C.: cAMP upregulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction. Int. Immunol. 6: 1333-1343, 1994.
24. LEE, H. J., KOYANO-NAKAGAWA, N., NAITO, Y., NISHIDA, J., ARAI, N., ARA, K-I. AND YOKOTA, T.: cAMP activates the IL-5 promoter synergistically with phorbol ester through the signaling pathway involving protein kinase A in mouse thymoma line EL-4. J. Immunol. 151: 6135-6142, 1993.
25. LEHMANN, V., FREUDENBERG, M. A. AND GALANOS, C.: Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165: 657-663, 1987.
26. LEIST, M., AUER-BARTH, S. AND WENDEL, A.: Tumor necrosis factor production in the perfused mouse liver and its pharmacological modulation by methylxanthines. J. Pharmacol. Exp. Therap. 276: 968-976, 1996.
27. MEYER ZUM BÜSCHENFELDE, K. H., HOOFNAGLE, J. AND MANNS, M.: Immunology and Liver. pp. 139-468, Kluwer Acad. Publ., Dordrecht, 1993.
28. MIETHKE, T., WAHL, C., HEEG, K., ECHTENACHER, B., KRAMMER, P. H. AND WAGNER, H.: T cell-mediated lethal shock in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor. J. Exp. Med. 175: 91-98, 1992.
29. MIZUHARA, H., O'NEILL, E., SEKI, N., OGAWA, T., KUSUNOKl, C., OTSUKA, K., SATOH, S., NIWA, M., SENOH, H. AND FUJIWARA, H.: T cell-activation-associated hepatic injury: Mediation by tumor necrosis factors and protection by IL-6. J. Exp. Med. 179: 1529-1537, 1994.
30. MOLNAR-KIMBER, K., YONNO, L., HEASLIP, R. AND WEICHMAN, B.: Modulation of TNF-α and IL-1β from endotoxin-stimulated monocytes by selective PDE isozyme inhibitors. Agents Actions 39: C77-C79, 1993.
31. MOORE, K. W., O'GARRA, A., DE WAAL MALEFYT, R., VIEIRA, P. AND MOSMANN, T. R.: Interleukin-10, Annu. Rev. Immunol. 11: 165-190, 1993.
32. MUNOZ, E., ZUBIAGA, A. M., MERROW, M., SAUTER, N. P. AND HUBER, B. T.: Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: Role of cAMP in T cell proliferation. J. Exp. Med. 172: 95-103, 1990.
33. NAGAKI, M., MUTO, Y., OHNISHI, H., YASUDA, S., SANO, K., NAITO, T., MAEDA, T., YAMADA, T. AND MORIWAKI, H.: Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology 106: 450-458, 1994.
34. NOVAK, T. J. AND ROTHENBERG, E. V.: cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc. Natl. Acad. Sci. U.S.A. 87: 9353-9357, 1990.
35. PLATZER, C., MEISEL, C., VOGT, K., PLATZER, M. AND VOLK, H.-D.: Upregulation of monocytic IL-10 by TNF-alpha and cAMP elevating drugs. Int. Immunol. 7: 517-523, 1995.
36. PRABHAKAR, U., LIPSHUTZ, D., BARTUS, J. O., SLIVJAK, M. J., SMITH, E. F., LEE, J. C. AND ESSER, K. M.: Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor. Int. J. Immunopharmacol. 16: 805-816, 1994.
37. 32P]cAMP. Anal. Biochem. 208: 155-160, 1993.
38. 2 receptors on rat Kupffer cells. Hepatology 19: 1454-1452, 1994.
39. SCHADE, U. F. AND SCHUDT, C.: The specific type III and type IV phosphodiesterase inhibitor zardaverine suppressed tumor necrosis factor by macrophages. Eur. J. Pharmacol. 230: 9-14, 1993.
40. 2-type T cell clone D10.G4.1. Immunopharmacology 30: 191-198, 1995.
41. SELDON, P. M., BARNES, P. J., MEJA, K. AND GIEMBYCZ, M. A.: Suppression of lipopolysaccharide-induced tumor necrosis factor-α generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase. Mol. Pharmacol. 48: 747-757, 1995.
42. SEMMLER, J., GEBERT, U., EISENHUT, T., MOELLER, T., SCHÖNHARTING, M. M., ALLÈRA, A. AND ENDRES, S.: Xanthine derivatives: Comparison between suppression of tumor necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity. Immunology 78: 520-525, 1993.
43. SEVERN, A., RAPSON, N. T., HUNTER, C. A. AND LIEW, F. Y.: Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists. J. Immunol. 148: 3441-3445, 1992.
44. SOMMER, N., LÖSCHMANN, P-A., NORTHOFF, G. H., WELLER, M., STEINBRECHER, A., STEINBACH, J. P., LICHTENFELS, R., MEYERMANN, R., RIETHMÜLLER, A., FONTANA, A., DICHGANS, J. AND MARTIN, R.: The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nature Med. 1: 244-248, 1995.
45. + T lymphocytes. Clin. Exp. Allergy 25: 616-624, 1995.
46. TIEGS, G., HENTSCHEL, J. AND WENDEL, A.: T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90: 196-203, 1992.
47. TIEGS, G., NIEHÖRSTER, M. AND WENDEL, A.: Leukocyte alterations do not account for hepatitis induced by endotoxin or TNF-α in galactosamine-sensitized mice. Biochem. Pharmacol. 40: 1317-1322, 1990.
48. TIEGS, G., WOLTER, M. AND WENDEL, A.: Tumor necrosis factor is a terminal mediator in D-galactosamine/endotoxin-induced hepatitis in mice. Biochem. Pharmacol. 38: 627-631, 1989.
49. WAAGE, A.: Presence and involvement of TNF in septic shock. In Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine, ed. by B. Beutler, pp. 275-283, Raven Press, New York, 1993.
50. WENDEL, A.: Biochemical pharmacology of inflammatory liver injury in mice, Methods Enzymol. 186: 675-680, 1990.
51. ZABEL, P., SCHADE, U. F. AND SCHLAAK, M.: Inhibition of endogenous TNF-α formation by pentoxyfylline. Immunobiology 187: 447-463, 1993.
52. ZAR, J. H.: Biostatistical Analysis, ed. by C. Englewoods, p. 201, Prentice Hall, New York, 1984.